Data from: Effect of information about the benefits and harms of mammography on women's decision making: the InforMa randomised controlled trial

Tipus de document: info:eu-repo/semantics/other

DOI: 10.5061/dryad.ft0207r

Publicacions relacionades: Pérez-Lacasta, M. J., Martínez-Alonso, M., Garcia, M., Sala, M., Perestelo-Pérez, L., Vidal, C., Codern-Bové, N., Feijoo-Cid, M., Toledo-Chávarri, A., Cardona, À., Pons, A., Carles-Lavila, M., Rue, M., & with the InforMa Group. (2019). Effect of information about the benefits and harms of mammography on women’s decision making: The InforMa randomised controlled trial. PLOS ONE, 14(3), e0214057. https://doi.org/10.1371/journal.pone.0214057

Grup de recerca: ECONOMIC CHALLENGES FOR THE NEXT GENERATION RESEARCH GROUP

Departament: Economia

Autor: Pérez-Lacasta, M.

Data alta repositori: 2022-09-19

Acció del programa de finançament: Instituto de Salud Carlos III, Award: PI14/00113

Any de publicació de la dataset: 2022

Matèria: Medicina

Identificador del investigador: 0000-0001-5906-5632

DOI de la publicació relacionada: 10.1371/journal.pone.0214057

Idioma: en

Publicat per (editora): Universitat Rovira i Virgili (URV)

Drets d'accés: info:eu-repo/semantics/openAccess

Resum: In Spain, women invited to breast screening are not usually informed about potential harms of screening. The objective of the InforMa study is to assess the effect of receiving information about the benefits and harms of breast screening on informed choice and other decision making outcomes, in women approaching the age of invitation to mammography screening.